Gene · 442906
Papers1,644
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,644
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biosensing circulating MicroRNAs in autoinflammatory skin diseases: Focus on Hidradenitis suppurativa. | Front Genet | 2024 | 38655054 | PubTator, text mining | PubMed |
| Role of Post-Transcriptional Regulation in Learning and Memory in Mammals. | Genes (Basel) | 2024 | 38540396 | PubTator, text mining | PubMed |
| Systematic review and meta-analysis of dysregulated microRNAs derived from liquid biopsies as biomarkers for amyotrophic lateral sclerosis. | Noncoding RNA Res | 2024 | 38511059 | PubTator, text mining | PubMed |
| Characterization of exosomal microRNAs in preterm infants fed with breast milk and infant formula. | Front Nutr | 2024 | 38304545 | PubTator, text mining | PubMed |
| Exercise immunology: Novel insights. | J Sport Health Sci | 2024 | 38278352 | PubTator, text mining | PubMed |
| Study of miRNA and lymphocyte subsets as potential biomarkers for the diagnosis and prognosis of gastric cancer. | PeerJ | 2024 | 38259671 | PubTator, text mining | PubMed |
| Non-coding RNAs in exercise immunology: A systematic review. | J Sport Health Sci | 2024 | 37925072 | PubTator, text mining | PubMed |
| Gene targeted and immune therapies for nodal and gastrointestinal follicular lymphomas. | World J Gastroenterol | 2023 | 38186866 | PubTator, text mining | PubMed |
| Potential therapeutic effects of milk-derived exosomes on intestinal diseases. | J Nanobiotechnology | 2023 | 38115131 | PubTator, text mining | PubMed |
| MicroRNAs as Potential Biomarkers of Environmental Exposure to Polycyclic Aromatic Hydrocarbons and Their Link with Inflammation and Lung Cancer. | Int J Mol Sci | 2023 | 38069307 | PubTator, text mining | PubMed |
| Characterization of lncRNA-associated ceRNA network to uncover novel potential biomarkers in coronary artery disease. | Medicine (Baltimore) | 2023 | 38013355 | PubTator, text mining | PubMed |
| Identification of a Novel Oxidative Stress- and Anoikis-Related Prognostic Signature and Its Immune Landscape Analysis in Non-Small Cell Lung Cancer. | Int J Mol Sci | 2023 | 38003378 | PubTator, text mining | PubMed |
| Molecular Networks of Platinum Drugs and Their Interaction with microRNAs in Cancer. | Genes (Basel) | 2023 | 38003016 | PubTator, text mining | PubMed |
| Interaction and Collaboration of SP1, HIF-1, and MYC in Regulating the Expression of Cancer-Related Genes to Further Enhance Anticancer Drug Development. | Curr Issues Mol Biol | 2023 | 37998757 | PubTator, text mining | PubMed |
| Discovering KYNU as a feature gene in hidradenitis suppurativa. | Int J Immunopathol Pharmacol | 2023 | 37997679 | PubTator, text mining | PubMed |
| MicroRNAs in Gingival Crevicular Fluid: An Observational Case-Control Study of Differential Expression in Periodontitis. | Noncoding RNA | 2023 | 37987369 | PubTator, text mining | PubMed |
| Decreased expression of hsa_circ_0112879 in oral squamous cell carcinoma and its clinicopathological implications. | Transl Cancer Res | 2023 | 37969381 | PubTator, text mining | PubMed |
| Alleviation of DSS-induced colitis via bovine colostrum-derived extracellular vesicles with microRNA let-7a-5p is mediated by regulating Akkermansia and β-hydroxybutyrate in gut environments. | Microbiol Spectr | 2023 | 37966243 | PubTator, text mining | PubMed |
| The emerging role of m6A modification of non-coding RNA in gastrointestinal cancers: a comprehensive review. | Front Cell Dev Biol | 2023 | 37965577 | PubTator, text mining | PubMed |
| Progress in the study of FOXO3a interacting with microRNA to regulate tumourigenesis development. | Front Oncol | 2023 | 37965449 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/442906/papers?page=2